Literature DB >> 15033448

Transposon-based RNAi delivery system for generating knockdown cell lines.

Arnold D Heggestad1, Lucia Notterpek, Bradley S Fletcher.   

Abstract

RNA interference is rapidly becoming a powerful tool for genetic analyses in mammalian systems. A potential drawback to transient small inhibitory RNA silencing is the short duration of downregulation it confers, usually only 24-72h. Viral-based vector systems for the long-term delivery of RNA hairpins have been developed, yet they require expertise in viral production and transduction. Here we describe a simple plasmid-based system for the generation of long-term gene knockdown utilizing RNA interference combined with the gene delivery capabilities of the mammalian Tc1-like transposon Sleeping Beauty. Designated Maleficent, this system is shown to downregulate exogenous expression of GFP in a constitutively positive cell line. In addition, targeting of the endogenously expressed lamin A gene results in long-term silencing with significant reduction in protein levels (> 95%). Maleficent therefore provides a relatively easy, efficient, and stable means of delivering RNAi hairpins to generate long-term gene-specific knockdown cell lines.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15033448     DOI: 10.1016/j.bbrc.2004.02.090

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Mutational analysis of the N-terminal DNA-binding domain of sleeping beauty transposase: critical residues for DNA binding and hyperactivity in mammalian cells.

Authors:  Stephen R Yant; Julie Park; Yong Huang; Jacob Giehm Mikkelsen; Mark A Kay
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

2.  High-resolution genome-wide mapping of transposon integration in mammals.

Authors:  Stephen R Yant; Xiaolin Wu; Yong Huang; Brian Garrison; Shawn M Burgess; Mark A Kay
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

3.  Somatic integration of an oncogene-harboring Sleeping Beauty transposon models liver tumor development in the mouse.

Authors:  Corey M Carlson; Joel L Frandsen; Nicole Kirchhof; R Scott McIvor; David A Largaespada
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-14       Impact factor: 11.205

Review 4.  Accelerating cancer modeling with RNAi and nongermline genetically engineered mouse models.

Authors:  Geulah Livshits; Scott W Lowe
Journal:  Cold Spring Harb Protoc       Date:  2013-11-01

5.  A transient transgenic RNAi strategy for rapid characterization of gene function during embryonic development.

Authors:  Bryan C Bjork; Yuko Fujiwara; Shannon W Davis; Haiyan Qiu; Thomas L Saunders; Peter Sandy; Stuart Orkin; Sally A Camper; David R Beier
Journal:  PLoS One       Date:  2010-12-16       Impact factor: 3.240

6.  The NIP7 protein is required for accurate pre-rRNA processing in human cells.

Authors:  Luis G Morello; Cédric Hesling; Patrícia P Coltri; Beatriz A Castilho; Ruth Rimokh; Nilson I T Zanchin
Journal:  Nucleic Acids Res       Date:  2010-08-26       Impact factor: 16.971

Review 7.  Epigenetic manipulation of gene expression: a toolkit for cell biologists.

Authors:  Rudy L Juliano; Vidula R Dixit; Hyunmin Kang; Tai Young Kim; Yuko Miyamoto; Dong Xu
Journal:  J Cell Biol       Date:  2005-06-20       Impact factor: 10.539

8.  L1 retrotransposon-mediated stable gene silencing.

Authors:  Nuo Yang; Lin Zhang; Haig H Kazazian
Journal:  Nucleic Acids Res       Date:  2005-03-30       Impact factor: 16.971

9.  Frog Prince transposon-based RNAi vectors mediate efficient gene knockdown in human cells.

Authors:  Christopher D Kaufman; Zsuzsanna Izsvák; Andrea Katzer; Zoltán Ivics
Journal:  J RNAi Gene Silencing       Date:  2005-09-02

10.  RNAi combining Sleeping Beauty transposon system inhibits ex vivo expression of foot-and-mouth disease virus VP1 in transgenic sheep cells.

Authors:  Shoulong Deng; Guangdong Li; Kun Yu; Xiuzhi Tian; Feng Wang; Wenting Li; Wuqi Jiang; Pengyun Ji; Hongbing Han; Juncai Fu; Xiaosheng Zhang; Jinlong Zhang; Yixun Liu; Zhengxing Lian; Guoshi Liu
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.